Results 1 to 10 of about 101,215 (169)

CKD-Associated Pruritus in Home Haemodialysis: A Signal for Routine Symptom Surveillance Rather Than a Severity Gradient. [PDF]

Nephrology (Carlton)
Wu M, Jin J, He Q.
europepmc   +1 more source

A Response to “Letter to the Editor Regarding ‘Dupilumab Versus Lebrikizumab Demonstrates Greater Likelihood of Achieving and Maintaining Improvements in Efficacy Outcomes Using a Placebo-Adjusted Indirect Treatment Comparison’”

Dermatology and Therapy
Sonja Ständer, Andreas Pinter, Firas G. Hougeir, Patricia Guyot, Yingxin Xu, Amy H. Praestgaard, Nick Freemantle, Ana B. Rossi, Gaëlle Bégo‑Le‑Bagousse, Zhixiao Wang, Kerry Noonan, Mike Bastian   +11 more
doaj   +1 more source

Minimal Clinically Important Difference in Chronic Pruritus Appears to be Dependent on Baseline Itch Severity

Acta Dermato-Venereologica, 2019
Claudia Riepe, Nani Osada, Adam Reich, Matthias Augustin, Claudia Zeidler, Sonja Ständer   +5 more
doaj   +1 more source

Literature Review: Recent Therapeutic Advances in The Management of Prurigo Nodularis: From Conventional Therapy to Biologics and Targeted Small-Molecule Agents. [PDF]

Clin Cosmet Investig Dermatol
Avriyanti E, Larasati R, Rengasamy S, Hidayah RMN, Tsaqilah L, Pangastuti M, Maharani RH.   +6 more
europepmc   +1 more source

Successful use of nemolizumab for refractory pruritus in cutaneous T-cell lymphoma. [PDF]

JAAD Case Rep
Li C, Rogers J, Raef H, Aspey L.
europepmc   +1 more source

Real-World Clinical Outcomes of Lebrikizumab in Moderate-to-Severe Atopic Dermatitis: A Report of Two Cases From Mexico. [PDF]

Cureus
Zavala Villafuerte G, Perez-Romero AG, Crocker Sandoval AB.   +2 more
europepmc   +1 more source

Successful treatment of Grover's disease with upadacitinib: A case report. [PDF]

SAGE Open Med Case Rep
Arora E, Oosterhuis R, Sutherland AE.
europepmc   +1 more source

Alterations in gut microbiota among maintenance hemodialysis patients with CKD-associated pruritus: a cross-sectional comparative study of two cohorts. [PDF]

Front Cell Infect Microbiol
Huang M, Chen S, Wang Y, Wang J, Liu J, Wu M, Lu B, Zhang A, Zhu Y, Zhu F, Liu H, Zeng X, Chen S, Zhou X, Lin R.   +14 more
europepmc   +1 more source

Efficacy, symptoms, and safety of second-line PBC therapies: a network meta-analysis. [PDF]

Front Pharmacol
Zhao W, Wu Z, Kou Q, Qiao S, Liu Z, Zhang X.   +5 more
europepmc   +1 more source

Abrocitinib and dupilumab bridging therapy for bullous pemphigoid with insufficient response to initial corticosteroid therapy: a case report. [PDF]

Front Immunol
Zhang H, Li L, Zhao S, Wu H, Zhu J.
europepmc   +1 more source